Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

PGC-1α protein found in muscle may contributes to the development of type 2 diabetes later in life

A Montr-al research team led by Jennifer Estall at the IRCM discovered that a protein found in muscle tissue may contribute to the development of type 2 diabetes later in life. The study's results, published in today's printed edition of the scientific journal American Journal of Physiology - Endocrinology and Metabolism, indicate that the protein could be a promising early predictor of increased diabetes risk.

15 Jan 2014

Research findings provide insights into risks associated with isolated mild hyperglycemia

Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into the risks associated with isolated mild hyperglycemia, according to a study in the January 15 issue of JAMA.

15 Jan 2014

New gold nanoparticle method allows for tracking studies of virus pathways in tissues

Enteroviruses are pathogenic viruses infecting humans. This group consists of polioviruses, coxsackieviruses, echoviruses and rhinoviruses. Enteroviruses are the most common causes of flu, but they also cause serious symptoms such as heart muscle infections and paralysis. Recently, enteroviruses have been linked with chronic diseases such as diabetes.

15 Jan 2014

New minimally invasive procedure for AF patients who are intolerant of blood-thinning medications

Sanford Heart Hospitals in Fargo and Sioux Falls now provide a new, minimally invasive procedure for atrial fibrillation (AF) patients who are intolerant of blood-thinning medications. Atrial fibrillation is a heart disorder that affects nearly 3 million adults in the United States.

15 Jan 2014

New programme to reduce risk of type 2 diabetes in people with schizophrenia

A group of researchers, led by Professor Richard Holt at the University of Southampton, are to investigate whether people with schizophrenia or first episode psychosis are able to reduce their weight through a structured education programme.

14 Jan 2014

High concentrations of serum omega-3 fatty acids may help reduce risk of type 2 diabetes

High concentrations of serum long-chain omega-3 fatty acids may help reduce the risk of type 2 diabetes, according to a University of Eastern Finland study published recently in Diabetes Care. The sources of these fatty acids are fish and fish oils.

14 Jan 2014

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

13 Jan 2014

Study: Variations in non-coding sections of genome might be main contributors to type 2 diabetes risk

Variations in non-coding sections of the genome might be important contributors to type 2 diabetes risk, according to a new study.

13 Jan 2014

Study finds pre-packaged set meals can help weight loss more than self-directed dieting

A study conducted by an obesity and food research centre in Hull has found that a provision of pre-packaged set meals can help people lose more weight compared to self-directed dieting.

10 Jan 2014

Hormone associated with improved glucose metabolism activates calorie-burning brown fat

Researchers at Joslin Diabetes Center have discovered that a hormone long associated with weight loss and improved glucose metabolism is linked to activation of calorie-burning brown fat.

10 Jan 2014

Researchers examine genetic variants associated with increased risk of type 2 diabetes

Contrary to a common belief, researchers have shown that genetic regions associated with increased risk of type 2 diabetes were unlikely to have been beneficial to people at stages through human evolution.

10 Jan 2014

Brown University biochemist targets diabetes

People with type 2 diabetes can make insulin but their bodies use it so poorly that glucose levels run amok. It's been difficult for scientists to understand what's going awry in the way that tiny, fast-moving proteins signal and regulate glucose metabolism. As a result, while drugs can help somewhat, many patients still must monitor their glucose and inject insulin.

10 Jan 2014

Low doses of anticancer drug can prevent development of diabetes mellitus type 1

Very low doses of a drug used to treat certain types of cancer protect the insulin-producing cells in the pancreas and prevent the development of diabetes mellitus type 1 in mice. The medicine works by lowering the level of so-called sterile inflammation. The findings have been made by researchers from the University of Copenhagen, the Technical University of Denmark and the University of Southern Denmark working with researchers in Belgium, Italy, Canada, Netherlands and the USA.

9 Jan 2014

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Gastric bypass surgery is a type of bariatric operation that results in weight loss and stimulates metabolic effects that treat diabetes and other cardiovascular risk factors such as diabetes, high cholesterol, and hypertension.

9 Jan 2014

Standards of hygiene may also contribute to development of auto-immune diseases in children

The incidence of auto-immune diseases like type 1 diabetes and allergies has risen dramatically in developed countries over the past fifty years. The reasons for this trend are not fully understood but a theory known as the 'hygiene hypothesis' links it to a rise in hygiene standards.

9 Jan 2014

Poor people more likely to become frail after a heart attack

As people get older, their bodies wear down and become less resilient. In old age, it's common for people to become "clinically frail," and this "frailty syndrome" is emerging in the field of public health as a powerful predictor of healthcare use and death.

9 Jan 2014

Sanford Health gifts $125M to establish Imagenetics program that integrates genomic medicine into primary care for adults

Sanford Health announced today Denny Sanford, the preeminent health care philanthropist in the United States, will gift the organization $125 million to establish Sanford Imagenetics, a first-of-its-kind program in the country that integrates genomic medicine into primary care for adults.

8 Jan 2014

JDRF joins with Brehm Center to investigate about lost beta cell function in type 1 diabetes

JDRF announced today the funding of an approximately $1 million collaboration with the University of Michigan's Brehm Center and the Brehm Coalition to evaluate a new hypothesis on why beta cells lose their ability to produce insulin, resulting in a diagnosis of type 1 diabetes (T1D).

8 Jan 2014

Quality of life considerations are key when patients consider bariatric surgery

While weight loss surgery offers one of the best opportunities to improve health and reduce obesity related illnesses, the nearly 100,000 Americans who undergo bariatric surgery each year represent only a small fraction of people who are medically eligible for the procedure. Among those who have surgery, Caucasian Americans are twice as likely as African Americans to have weight loss surgery. On the surface, the data appear to signal racial disparity, but when researchers at Beth Israel Deaconess Medical Center dug deeper to ask why this variation exists, the answer was more complicated.

7 Jan 2014

FDA grants orphan drug designation for DiaVacs' type 1 diabetes mellitus therapy

DiaVacs, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for the company's type 1 diabetes mellitus (T1DM) therapy.

6 Jan 2014

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

PGC-1α protein found in muscle may contributes to the development of type 2 diabetes later in life

Research findings provide insights into risks associated with isolated mild hyperglycemia

New gold nanoparticle method allows for tracking studies of virus pathways in tissues

New minimally invasive procedure for AF patients who are intolerant of blood-thinning medications

New programme to reduce risk of type 2 diabetes in people with schizophrenia

High concentrations of serum omega-3 fatty acids may help reduce risk of type 2 diabetes

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

Study: Variations in non-coding sections of genome might be main contributors to type 2 diabetes risk

Study finds pre-packaged set meals can help weight loss more than self-directed dieting

Hormone associated with improved glucose metabolism activates calorie-burning brown fat

Researchers examine genetic variants associated with increased risk of type 2 diabetes

Brown University biochemist targets diabetes

Low doses of anticancer drug can prevent development of diabetes mellitus type 1

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Standards of hygiene may also contribute to development of auto-immune diseases in children

Poor people more likely to become frail after a heart attack

Sanford Health gifts $125M to establish Imagenetics program that integrates genomic medicine into primary care for adults

JDRF joins with Brehm Center to investigate about lost beta cell function in type 1 diabetes

Quality of life considerations are key when patients consider bariatric surgery

FDA grants orphan drug designation for DiaVacs' type 1 diabetes mellitus therapy

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in